I think if you actually read what I wrote, instead of saying the same thing over and over, you'd see that I agreed with your criticism of one of my points. What you showed quite correctly was that the writers of that Brazil paper couldn't have been using the current trials.

But you seemed strangely mute about my other point --that the language in the paper is the kind of thing that CYDY can use to disabuse the FDA of its claim that Leron offers no clinical benefit against Covid.

Bashers as you know always emphasize the negative, and exclude the positive.